Table 5.
Pathway name
|
Protein ID
|
Number
|
P
value
|
Primary immunodeficiency | IGG2C, Q5BJZ2, F1LXY6, Q569B3 | 4 | 0.009 |
Oxidative phosphorylation | ATP5H, ATPO, COX41, AT5F1, Q5UAJ5, NMES1, ATP5L | 7 | 0.002 |
Nitrogen metabolism | CAH1, CAH3, CPSM | 3 | 0.001 |
Natural killer cell mediated cytotoxicity | GRZ2, IGG2C, Q5U1Y2, Q5BJZ2, F1LXY6, Q569B3 | 6 | 0.005 |
Intestinal immune network for IgA production | IGG2C, Q5BJZ2, Q6MG98, F1LXY6, Q569B3 | 5 | 0.002 |
Fc gamma R-mediated phagocytosis | IGG2C, Q5U1Y2, Q5BJZ2, F1LXY6, Q569B3 | 5 | 0.040 |
Complement and coagulation cascades | Q5M7T5, Q99N82, Q7TQ70, FIBA | 4 | 0.031 |
B cell receptor signalling pathway | IGG2C, Q5U1Y2, Q5BJZ2, F1LXY6, Q569B3 | 5 | 0.020 |
M: Dextran sulfate sodium-induced ulcerative colitis model group; HM: Herb-partitioned moxibustion group; IgA: Immunoglobulin A; ATP5L: ATP synthase subunit g.